Home › Markets › Health Care › EOCN

Eocene Ltd. (EOCN)

EOCN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$3.17
-1.71% on the day
Market cap
$3.3M
Nano cap
Revenue
No annual revenue filed since the period ending 2020-12-31
Net income
No annual revenue filed since the period ending 2020-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerEOCN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryIsrael
IPO year2014
SEC CIK0001595353
SEC industry codePharmaceutical Preparations
Incorporated inL3

Financials

No annual revenue filed since the period ending 2020-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2026-09-02
Latest annual report20-F2026-03-31
Latest quarterly / interim6-K2026-09-09

Source: SEC EDGAR submissions feed, 381 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CAPSCapstone Holding Corp.$0.1242-6.83%$3.3M
GRIGRI Bio Inc.$1.55-1.27%$3.4M
SXTP60 Degrees Pharmaceuticals Inc.$0.9000-1.70%$3.2M
CMNDClearmind Medicine Inc. Common Shares$6.23-4.74%$3.2M
RDHLRedhill Biopharma Ltd.$0.5150-3.45%$3.1M
APVOAptevo Therapeutics Inc.$1.73-5.79%$3.1M
CVKDCadrenal Therapeutics Inc.$0.9970+14.28%$3.6M
XRTXXORTX Therapeutics Inc. Common Shares$1.68-2.33%$3.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier